Churg-Strauss Syndrome

Phase 4 trials (7)

• methylprednisolone
• prednisone
• naltrexone
• hydroxychloroquine
• mycophenolate
• cyclophosphamide
• azathioprine

Phase 3 trials (3)

• benralizumab
• mepolizumab
• prednisolone

Phase 2 trials (2)

• rituximab
• ns-229

Phase 1 trials (1)

• autologous mononuclear stem cell

Other trials (4)

• cyclosporine
• Anti-thymocyte Globulin (Rabbit)
• infliximab
• sargramostim

Organization Involved with Phase 4 Indications (5)

• Medical Research Council
• University of London
• University of Lyon
• French Vasculitis Study Group
• University of Paris

Organization Involved with Phase 3 Indications (4)

• AstraZeneca
• GlaxoSmithKline
• National Institute of Allergy and Infectious Diseases (NIAID)
• University of Colorado, Denver

Organization Involved with Phase 2 Indications (10)

• Genentech
• Biogen
• Teva
• National Center for Research Resources (NCRR)
• University of Pennsylvania
• Harvard University
• University of Parma
• Mayo Clinic
• University of Cincinnati
• Universitaetsklinikum Schleswig-Holstein

Organization Involved with Phase 1 Indications (1)

• University of Pittsburgh

Organization Involved with Other Experimental Indications (2)

• University of Toronto
• University of Minnesota